Established in 2017, Kemiex provides a commodity exchange platform to traders, buyers and sellers that meet predefined quality assurance and financial due diligence criteria. The platform instantly connects users to a global network of qualified counterparties, enabling them to minimize transaction lead times, achieve more competitive prices and to stay in full control of the whole trading activity. The platform is accessible 24/7 and covers the full trade process such as quoting a product request, private negotiations, trade execution, document management and other value-add services such as reporting and pricing intelligence.
With a team of nine employees, the startup is now ready to take further steps, thanks to the recently closed seed financing round. The private placement lifts its post-money valuation to an eight-digit Swiss Francs figure. The funds will be used for IT and sales development. This includes the launch of the world’s first online trading solution for Active Pharmaceutical Ingredient (APIs) and Additives. The introduction of an online trading platform marks a quantum leap for these industries as currently many market participants are facing issues to identify reliable and compliant counterparties globally.
The API market is an attractive and growing market globally. Recent research found that the global API market is expected to grow at an annual growth rate of about 6% to exceed US$ 215 billion by 2023. Growing at a similar pace, the global food additives market is expected to cross US$ 65 billion by 2022, while the veterinary healthcare market is about to exceed US$ 40bn and the animal feed additives market US$ 20bn respectively.
CEO Pau Franquet on the capital increase: “Our team is excited to introduce this new B2B trading solution to the pharma, vet, food and feed industries and create a superior one-stop-shop for trading APIs, Additives & Excipients. We are confident to combine best practices from several industries and contribute to the digitalization of sourcing APIs.”